Industry News
A Smoking Gun In Lung Cancer Epigenetics
Feb 20, 2013
Recent studies have identified correlations between cigarette smoke-induced microRNA (miRNA) expression and different aspects of lung cancer; however, it is unclear how miRNA expression directly contributes to carcinogenesis. MiRNAs regulate the expression of target genes and can have a significant impact on when and how well different gene products are expressed... Read More
Intravenous Fluid Used To Increase Blood Volume In Critically Ill Patients Associated With Increased Risk Of Death, Kidney Injury
Feb 19, 2013
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch, compared with other resuscitation solutions, was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA... Read More
Intravenous Fluid Used To Increase Blood Volume In Critically Ill Patients Associated With Increased Risk Of Death, Kidney Injury
Feb 19, 2013
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch, compared with other resuscitation solutions, was not associated with decreased mortality, according to an article appearing in the February 20 issue of JAMA... Read More
Dako Receives FDA Approval For Fast, Accurate, Nontoxic FISH Assay For Cancer Diagnostics
Feb 19, 2013
Dako, an Agilent Technologies Company, has introduced IQISH technology in the United States. The technology will reduce the turnaround time for cancer evaluation from two days to three and a half hours. This will ease the waiting time and associated anxiety for the patient and allow physicians to more quickly initiate targeted cancer treatments... Read More
Potential New Therapeutic Target For Treating Non-Small Cell Lung Cancer
Feb 19, 2013
Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. The study appeared in the online issue of Oncogene. The IKBKE gene is part of a family of enzyme complexes involved in increasing cellular inflammation... Read More
Adhesive Protein Inspired By Mussels Harnessed For Biomedical Applications
Feb 19, 2013
When it comes to sticking power under wet conditions, marine mussels are hard to beat. They can adhere to virtually all inorganic and organic surfaces, sustaining their tenacious bonds in saltwater, including turbulent tidal environments. Northwestern University's Phillip B... Read More
Promising New Approach To Preventing Progression Of Breast Cancer
Feb 19, 2013
Doctors currently struggle to determine whether a breast tumor is likely to shift into an aggressive, life-threatening mode - an issue with profound implications for treatment. Now a group from The Scripps Research Institute (TSRI) has identified a mechanism through which mitochondria, the powerhouses of a cell, control tumor aggressiveness... Read More
Designer Blood Clots Could Help Injured Soldiers On The Battlefield
Feb 19, 2013
When it comes to healing the terrible wounds of war, success may hinge on the first blood clot - the one that begins forming on the battlefield right after an injury. Researchers exploring the complex stream of cellular signals produced by the body in response to a traumatic injury believe the initial response - formation of a blood clot - may control subsequent healing... Read More
Potential New Therapeutic Target For Treating Non-Small Cell Lung Cancer
Feb 19, 2013
Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. The study appeared in the online issue of Oncogene. The IKBKE gene is part of a family of enzyme complexes involved in increasing cellular inflammation... Read More
Promising New Approach To Preventing Progression Of Breast Cancer
Feb 19, 2013
Doctors currently struggle to determine whether a breast tumor is likely to shift into an aggressive, life-threatening mode - an issue with profound implications for treatment. Now a group from The Scripps Research Institute (TSRI) has identified a mechanism through which mitochondria, the powerhouses of a cell, control tumor aggressiveness... Read More
Previous Page Next Page